Related by context. Frequent words. (Click for all words.) 67 leukemia CLL 67 heavily pretreated 67 relapsed refractory 67 indolent NHL 67 relapsed multiple myeloma 66 mRCC 66 plus dexamethasone 66 metastatic renal cell carcinoma 66 chlorambucil 65 relapsed refractory multiple myeloma 64 plus prednisone 64 HER2 positive metastatic breast 63 heavily pretreated patients 63 superficial bladder cancer 63 chronic lymphocytic leukemia CLL 63 relapsing multiple sclerosis 63 Relapsed 63 chronic HCV 62 DOXIL 62 GvHD 62 chronic hepatitis B. 62 Pegasys ® 62 docetaxel chemotherapy 62 vinorelbine 62 Chronic Hepatitis C 62 metastatic hormone refractory 61 voriconazole 61 pancreatic NET 61 TORISEL 61 Engerix B 61 PREZISTA r 61 plus methotrexate 61 Irinotecan 61 KRAS wild 61 Natalizumab 61 chronic HCV infection 61 complete remissions 61 DLBCL 61 Solid Tumors 60 coinfected 60 Fludara 60 HCV genotype 1 60 tumor lysis syndrome 60 primary hypercholesterolemia 60 lymphoma CTCL 60 refractory multiple myeloma 60 evaluable 60 FOLFIRI 60 Gemzar ® 60 dacarbazine 60 follicular lymphoma 60 patients evaluable 60 xenograft models 60 mycophenolate mofetil 60 Rituximab 60 rituximab 60 Rheumatoid Arthritis RA 60 Epratuzumab 60 advanced carcinoid 60 HCV infected 60 diagnosed multiple myeloma 59 cytogenetic response 59 RECIST criteria 59 relapsing MS 59 pertuzumab 59 hepatitis C HCV 59 carboplatin paclitaxel 59 febrile neutropenia 59 follicular B 59 castration resistant prostate cancer 59 azacitidine 59 nilotinib 59 allogeneic stem cell 59 Secondary endpoints include 59 Metastatic Colorectal Cancer 59 % CI #.#-#.# [007] 58 HCV genotype 58 plus gemcitabine 58 PsA 58 Traficet EN 58 cell malignancies 58 B CLL 58 severe renal impairment 58 REVLIMID R 58 % CI #.#-#.# [003] 58 veltuzumab 58 axitinib 58 chemoradiotherapy 58 Trastuzumab 58 seroprotection 58 Response Evaluation Criteria 58 Combination therapy 58 COPAXONE R 58 FOLFOX 58 evaluable patients 58 fludarabine 58 relapsing remitting multiple sclerosis 58 acute promyelocytic leukemia APL 58 cholangiocarcinoma 58 goserelin 58 nab paclitaxel